Outlook Therapeutics (OTLK) Reports Positive Data from Pivotal Phase 3 NORSE TWO Trial of ONS-5010

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. NKE
3. PANW
4. CL
5. SNDK
6. TAP
7. DELL
8. ROIV
9. ANET
10. BE

Go back to Outlook Therapeutics (OTLK) Reports Positive Data from Pivotal Phase 3 NORSE TWO Trial of ONS-5010
Otter Lake Resources, Inc. New (NASDAQ: OTLK) Delayed: 0.67 +0.02 (3.08%)
Previous Close $0.65    52 Week High $0.03 
Open $0.66    52 Week Low $0.01 
Day High $0.70    P/E N/A 
Day Low $0.65    EPS $0.00 
Volume 6,395,728       

(NASDAQ: OTLKW) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High $ 
Open $6.93    52 Week Low $ 
Day High $0.03    P/E N/A 
Day Low $0.03    EPS $ 
Volume 176,912